The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis - The French Experience

Lupus

Volumn 5, Issue SUPPL. 1, 1996, Pages

  Kahan, A ^a,b   Menkes C J ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hôpital Cochin ^*  (France)

Author keywords

Antimalarials; Combination therapy; Disease modifying anti rheumatic drugs; Hydroxychloroquine; Rheumatoid arthritis

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AUROTHIOMALATE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DAPSONE; HYDROXYCHLOROQUINE; METHOTREXATE; SALAZOSULFAPYRIDINE;

ARTICLE; BACTERIAL PNEUMONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FRANCE; HEMOLYTIC ANEMIA; HERPES ZOSTER; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOPENIA; META ANALYSIS; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RASH; RHEUMATOID ARTHRITIS;

ANTIMALARIALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; CONTROLLED CLINICAL TRIALS; DRUG THERAPY, COMBINATION; FRANCE; HUMANS; META-ANALYSIS;

EID: 0029889794     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Scott DL et al. Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study. Br J Rheumatol 1989; 28: 128-133.
2. Paulus HE. The use of combinations of disease-modifying anti-rheumatic agents in rheumatoid arthritis. Arthritis Rheum 1990; 33: 113-120.
3. Wilke WS, Clough JD. Therapy for rheumatoid arthritis: combinations of disease-modifying drugs and new paradigms of treatment. Semin Arthritis Rheum 1991; 21: 21-34.
4. Fox RI. Mechanism of action of hydroxycbloroquine as an anti-rheumatic drug. Semin Arthritis Rheum 1993; 23: 82-91.
5. McCarty DJ, Carrera GF. Intractable rheumatoid arthritis: treatment with combined cyclophosphamide, azathioprine and hydroxychloroquine. JAMA 1982; 248: 1718-1723.
6. Csuka ME, Carrera GF, McCarty DJ. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine and hydroxychloroquine: a follow-up study. JAMA 1986, 255: 2315-2319.
7. McCarty DJ et al. Combination drug therapy of seropositive rheumatoid arthritis. J Rheumatol 1995; 22: 1636-1645.
8. Langevitz P, Kaplinsky N, Ehrenfeld M, Pras M. Intractable RA - Treatment with combined methotrexate, azathioprine and hydroxychloroquine. Br J Rheumatol 1989; 28: 271-272.
9. O'Dell J et al. Efficacy of triple DMARD therapy in RA patients with suboptimal responses to methotrexate: results of an open-label study (Abstract). Arthritis Rheum 1995; 38 (Suppl): S186.
10. Porter DR, Capell HA, Hunter J. Combination therapy in rheumatoid arthritis - no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy. J Rheumatol 1993; 20: 645-649.
11. Martin M et al. A combination of D-penicillamine and hydroxychloroquine for the treatment of rheumatoid arthritis (Abstract). Ann Rheum Dis 1982; 41: 208.
12. Bunch TW, O'Duffy JD, Tompkins RB, O'Fallon WM. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum 1984; 27: 267-276.
13. Gibson T et al. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis: a comparative study. Br J Rheumatol 1987; 26: 279-284.
14. Faarvang KL et al. Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial. Ann Rheum Dis 1993; 52: 711-715.
15. Haar D et al. A double-blind comparative study of hydroxychloroquine and dapsone, alone and in combination, in rheumatoid arthritis. Scand J Rheumatol 1993; 22: 113-118.
16. Fries JF, Singh G, Lenert L, Furst DE. Aspirin, hydroxychloroquine and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum 1990; 33: 1611-1619.
17. Seideman P et al. Chloroquine reduces the bioavailability of methotrexate in patients with rheumatoid arthritis. A possible mechanism of reduced hepatotoxicity. Arthritis Rheum 1994; 37: 830-833.
18. Combe B, Guttierez M, Anaya JM, Sany J. Possible efficacy of hydroxychloroquine on accelerated nodulosis during methotrexate therapy for rheumatoid arthritis. J Rheumatol 1993; 20: 755-756.
19. Trnavsky K, Gatterova J, Linduskova M, Peliskova Z Combination therapy with hydroxychloroquine and methotrexate in rheumatoid arthritis. Z Rheumatol 1993; 52: 292-296.
20. Ferraz MB et al. Combination therapy with methotrexate and chloroquine in rheumatoid arthritis - a multicenter randomized placebo-controlled trial Scand J Rheumatol 1994; 23: 231-236.
21. Clegg DO. Combination hydroxychloroquine and methotrexate in the treatment of rheumatoid arthritis (Abstract). Arthritis Rheum 1993; 36 (Suppl): S53.
22. O'Dell J et al. Triple DMARD therapy for rheumatoid arthritis: efficacy (Abstract). Arthritis Rheum 1994; 37 (Suppl): S295.
23. Tiliakos NA. Low-dose cytotoxic drug combination therapy in intractable rheumatoid arthritis: two years later (Abstract). Arthritis Rheum 1986; 29 (Suppl): S79.
24. Felson DT, Anderson JJ, Meenan RF. The efficacy and toxicity of combination therapy in rheumatoid arthritis. A meta-analysis. Arthritis Rheum 1994; 37: 1487-1491.
25. Taggart AJ et al. Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis. Br J Rheumatol 1987; 26: 32-36.
26. Williams HJ et al. Comparison of auranofin, methotrexate and the combination of both in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 1992; 35: 259-269.
27. Willkens RF et al. Comparison of azathioprine, methotrexate and the combination of both in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 1992; 35: 849-856.